AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 86 filers reported holding AKCEA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $143,000 | +150.9% | 7,876 | +88.8% | 0.00% | 0.0% |
| Q2 2020 | $57,000 | +5600.0% | 4,172 | +4072.0% | 0.00% | – |
| Q1 2020 | $1,000 | -99.4% | 100 | -99.0% | 0.00% | -100.0% |
| Q4 2019 | $164,000 | +2633.3% | 9,672 | +4736.0% | 0.01% | – |
| Q1 2019 | $6,000 | +100.0% | 200 | +104.1% | 0.00% | – |
| Q4 2018 | $3,000 | -96.3% | 98 | -97.2% | 0.00% | -100.0% |
| Q2 2018 | $82,000 | +100.0% | 3,477 | +118.0% | 0.01% | +25.0% |
| Q1 2018 | $41,000 | -38.8% | 1,595 | -58.8% | 0.00% | -55.6% |
| Q4 2017 | $67,000 | -65.6% | 3,873 | -45.1% | 0.01% | -43.8% |
| Q3 2017 | $195,000 | – | 7,054 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |